NO20043717L - Dihydrotiafenantren-karbonylguanidiner, fremgangsmate for fremstilling derav, deres anvendelse som medikament eller diagnostikum - Google Patents
Dihydrotiafenantren-karbonylguanidiner, fremgangsmate for fremstilling derav, deres anvendelse som medikament eller diagnostikumInfo
- Publication number
- NO20043717L NO20043717L NO20043717A NO20043717A NO20043717L NO 20043717 L NO20043717 L NO 20043717L NO 20043717 A NO20043717 A NO 20043717A NO 20043717 A NO20043717 A NO 20043717A NO 20043717 L NO20043717 L NO 20043717L
- Authority
- NO
- Norway
- Prior art keywords
- dihydrotiaphenanthrene
- diagnostic
- drug
- preparation
- guanidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10204989A DE10204989A1 (de) | 2002-02-07 | 2002-02-07 | Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| PCT/EP2003/000653 WO2003066620A1 (de) | 2002-02-07 | 2003-01-23 | Dihydro-thia-phenanthren-carbonyl-guanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043717L true NO20043717L (no) | 2004-11-03 |
Family
ID=27618378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043717A NO20043717L (no) | 2002-02-07 | 2004-09-06 | Dihydrotiafenantren-karbonylguanidiner, fremgangsmate for fremstilling derav, deres anvendelse som medikament eller diagnostikum |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1474414B1 (es) |
| JP (1) | JP4410564B2 (es) |
| KR (1) | KR20040096555A (es) |
| CN (1) | CN1319963C (es) |
| AR (1) | AR038393A1 (es) |
| AT (1) | ATE380805T1 (es) |
| AU (1) | AU2003208337A1 (es) |
| BR (1) | BR0307495A (es) |
| CA (1) | CA2475093A1 (es) |
| CO (1) | CO5601008A2 (es) |
| DE (2) | DE10204989A1 (es) |
| HK (1) | HK1073656A1 (es) |
| HR (1) | HRP20040721A2 (es) |
| HU (1) | HUP0402595A2 (es) |
| MA (1) | MA27171A1 (es) |
| MX (1) | MXPA04007476A (es) |
| NO (1) | NO20043717L (es) |
| NZ (1) | NZ534536A (es) |
| PE (1) | PE20030963A1 (es) |
| PL (1) | PL370271A1 (es) |
| RS (1) | RS69204A (es) |
| RU (1) | RU2306311C2 (es) |
| TW (1) | TWI268927B (es) |
| WO (1) | WO2003066620A1 (es) |
| ZA (1) | ZA200406015B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200614995A (en) | 2004-11-10 | 2006-05-16 | Nicholas Piramal India Ltd | Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60262887A (ja) * | 1984-06-11 | 1985-12-26 | Mitsubishi Chem Ind Ltd | 液晶組成物 |
| GB8505756D0 (en) * | 1985-03-06 | 1985-04-11 | Erba Farmitalia | Tricyclic dibenzo condensed derivatives |
| US4948806A (en) * | 1988-03-30 | 1990-08-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| DE19601303A1 (de) * | 1996-01-16 | 1997-07-17 | Boehringer Ingelheim Kg | Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln |
| CA2370607A1 (en) * | 1999-04-23 | 2000-11-02 | Bristol-Myers Squibb Company | Bicyclic acyl guanidine sodium/proton exchange inhibitors and method |
| DE10001879A1 (de) * | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
2002
- 2002-02-07 DE DE10204989A patent/DE10204989A1/de not_active Withdrawn
-
2003
- 2003-01-23 NZ NZ534536A patent/NZ534536A/en unknown
- 2003-01-23 DE DE50308787T patent/DE50308787D1/de not_active Expired - Lifetime
- 2003-01-23 BR BR0307495-1A patent/BR0307495A/pt not_active IP Right Cessation
- 2003-01-23 HU HU0402595A patent/HUP0402595A2/hu unknown
- 2003-01-23 RU RU2004126854/04A patent/RU2306311C2/ru not_active IP Right Cessation
- 2003-01-23 PL PL03370271A patent/PL370271A1/xx not_active Application Discontinuation
- 2003-01-23 CA CA002475093A patent/CA2475093A1/en not_active Abandoned
- 2003-01-23 AT AT03706373T patent/ATE380805T1/de not_active IP Right Cessation
- 2003-01-23 WO PCT/EP2003/000653 patent/WO2003066620A1/de active IP Right Grant
- 2003-01-23 MX MXPA04007476A patent/MXPA04007476A/es active IP Right Grant
- 2003-01-23 JP JP2003565993A patent/JP4410564B2/ja not_active Expired - Fee Related
- 2003-01-23 RS YU69204A patent/RS69204A/sr unknown
- 2003-01-23 EP EP03706373A patent/EP1474414B1/de not_active Expired - Lifetime
- 2003-01-23 KR KR10-2004-7012241A patent/KR20040096555A/ko not_active Application Discontinuation
- 2003-01-23 AU AU2003208337A patent/AU2003208337A1/en not_active Abandoned
- 2003-01-23 CN CNB038035502A patent/CN1319963C/zh not_active Expired - Fee Related
- 2003-01-30 TW TW092102087A patent/TWI268927B/zh not_active IP Right Cessation
- 2003-02-05 AR ARP030100363A patent/AR038393A1/es unknown
- 2003-02-05 PE PE2003000136A patent/PE20030963A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 MA MA27802A patent/MA27171A1/fr unknown
- 2004-07-28 ZA ZA200406015A patent/ZA200406015B/en unknown
- 2004-08-06 CO CO04076743A patent/CO5601008A2/es not_active Application Discontinuation
- 2004-08-06 HR HR20040721A patent/HRP20040721A2/hr not_active Application Discontinuation
- 2004-09-06 NO NO20043717A patent/NO20043717L/no not_active Application Discontinuation
-
2005
- 2005-07-21 HK HK05106161A patent/HK1073656A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0307495A (pt) | 2004-12-28 |
| JP4410564B2 (ja) | 2010-02-03 |
| ATE380805T1 (de) | 2007-12-15 |
| HUP0402595A2 (hu) | 2005-04-28 |
| AR038393A1 (es) | 2005-01-12 |
| HK1073656A1 (en) | 2005-10-14 |
| TWI268927B (en) | 2006-12-21 |
| RS69204A (en) | 2006-12-15 |
| CN1630649A (zh) | 2005-06-22 |
| KR20040096555A (ko) | 2004-11-16 |
| CN1319963C (zh) | 2007-06-06 |
| TW200404792A (en) | 2004-04-01 |
| ZA200406015B (en) | 2005-11-14 |
| DE50308787D1 (de) | 2008-01-24 |
| MXPA04007476A (es) | 2004-11-10 |
| MA27171A1 (fr) | 2005-01-03 |
| CA2475093A1 (en) | 2003-08-14 |
| JP2005517015A (ja) | 2005-06-09 |
| DE10204989A1 (de) | 2003-08-21 |
| EP1474414B1 (de) | 2007-12-12 |
| HRP20040721A2 (en) | 2005-06-30 |
| WO2003066620A1 (de) | 2003-08-14 |
| AU2003208337A1 (en) | 2003-09-02 |
| PL370271A1 (en) | 2005-05-16 |
| CO5601008A2 (es) | 2006-01-31 |
| EP1474414A1 (de) | 2004-11-10 |
| PE20030963A1 (es) | 2004-01-12 |
| RU2004126854A (ru) | 2006-01-27 |
| RU2306311C2 (ru) | 2007-09-20 |
| NZ534536A (en) | 2006-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1592457T3 (da) | Folat-vinblastin-konjugat som lægemiddel | |
| DK1549341T3 (da) | Mod vævsfaktor rettede antistoffer som antikoagulanter | |
| NO20054876D0 (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
| NO20040356L (no) | Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling. | |
| NO20054329D0 (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
| NO20054555D0 (no) | Farmasoytiske preparater som omfatter syrestabilisert insulin | |
| DE602005018076D1 (de) | Enantioselektive herstellung von chinolin-derivaten | |
| NO20044322L (no) | Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament | |
| NO20041785L (no) | Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt | |
| DK1670458T3 (da) | 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika | |
| DK1838315T3 (da) | Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til fremstilling heraf, deres anvendelse som medikament samt medikamenter indeholdende dem | |
| DK1453810T3 (da) | Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament indeholdende samme | |
| DE602005014280D1 (de) | Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten | |
| NO20022801D0 (no) | Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse | |
| DK1816121T3 (da) | 9-chlor-15-deoxyprostaglandinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som medikamenter | |
| DK1513834T3 (da) | Substituerede thiophener, fremgangsmåde til deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament, som indeholder dem | |
| NO20043717L (no) | Dihydrotiafenantren-karbonylguanidiner, fremgangsmate for fremstilling derav, deres anvendelse som medikament eller diagnostikum | |
| ITTO20030850A1 (it) | Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro. | |
| ITMI20031994A1 (it) | Procedimento per la preparazione di fludarabina fosfato | |
| DK1685096T3 (da) | Pentafluorsulfanyl-benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikamenter indeholdende dem | |
| ITMI20041920A1 (it) | Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina | |
| DE602005013241D1 (de) | Verfahren zur herstellung von chinuclidiniumcarbamatderivaten | |
| NO20043009L (no) | Substituerte imidazolidiner, fremgangsmate for fremstilling derav, deres anvendelse som et legemiddel eller for diagnose og legemiddel inneholdende substituerte imidazolidiner | |
| ITMI20030018A1 (it) | Procedimento per la preparazione di composti mono- | |
| IT1338456B1 (it) | Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |